A toolbox of IgG subclass-switched recombinant monoclonal antibodies for enhanced multiplex immunolabeling of brain.
Nicolas P AndrewsJustin X BoeckmanColleen F ManningJoe Truong NguyenHannah BechtoldCamelia DumitrasBelvin GongKimberly NguyenDeborah van der ListKarl D MurrayJoAnne EngebrechtJames S TrimmerPublished in: eLife (2019)
Generating recombinant monoclonal antibodies (R-mAbs) from mAb-producing hybridomas offers numerous advantages that increase the effectiveness, reproducibility, and transparent reporting of research. We report here the generation of a novel resource in the form of a library of recombinant R-mAbs validated for neuroscience research. We cloned immunoglobulin G (IgG) variable domains from cryopreserved hybridoma cells and input them into an integrated pipeline for expression and validation of functional R-mAbs. To improve efficiency over standard protocols, we eliminated aberrant Sp2/0-Ag14 hybridoma-derived variable light transcripts using restriction enzyme treatment. Further, we engineered a plasmid backbone that allows for switching of the IgG subclasses without altering target binding specificity to generate R-mAbs useful in simultaneous multiplex labeling experiments not previously possible. The method was also employed to rescue IgG variable sequences and generate functional R-mAbs from a non-viable cryopreserved hybridoma. All R-mAb sequences and plasmids will be archived and disseminated from open source suppliers.
Keyphrases
- escherichia coli
- induced apoptosis
- high throughput
- cell free
- systematic review
- poor prognosis
- randomized controlled trial
- binding protein
- cell cycle arrest
- real time pcr
- cord blood
- crispr cas
- white matter
- multiple sclerosis
- adverse drug
- resting state
- single cell
- cell death
- klebsiella pneumoniae
- genetic diversity
- dna binding
- highly efficient
- endoplasmic reticulum stress